Global Metabolomics Biomarker Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Metabolomics Biomarker Revenue
• 1.4 Market by Type
  • 1.4.1 Global Metabolomics Biomarker Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Gas chromatography
  • 1.4.3 High-performance liquid chromatography
  • 1.4.4 Ultra-performance liquid chromatography
  • 1.4.5 Nuclear magnetic resonance
  • 1.4.6 Mass spectrometry
  • 1.4.7 Surface-based mass analysis
  • 1.4.8 Bioinformatics
• 1.5 Market by Application
  • 1.5.1 Global Metabolomics Biomarker Market Share by Application: 2020 VS 2026
  • 1.5.2 Toxicological studies
  • 1.5.3 Drug testing
  • 1.5.4 Cancer
  • 1.5.5 Cardiovascular disorders
  • 1.5.6 Neurological disorders
  • 1.5.7 Inborn errors of metabolism
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Metabolomics Biomarker Market Perspective (2015-2026)
• 2.2 Global Metabolomics Biomarker Growth Trends by Regions
  • 2.2.1 Metabolomics Biomarker Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Metabolomics Biomarker Historic Market Share by Regions (2015-2020)
  • 2.2.3 Metabolomics Biomarker Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Metabolomics Biomarker Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Metabolomics Biomarker Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Metabolomics Biomarker Players by Market Size
  • 3.1.1 Global Top Metabolomics Biomarker Players by Revenue (2015-2020)
  • 3.1.2 Global Metabolomics Biomarker Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Metabolomics Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Metabolomics Biomarker Market Concentration Ratio
  • 3.2.1 Global Metabolomics Biomarker Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Metabolomics Biomarker Revenue in 2019
• 3.3 Metabolomics Biomarker Key Players Head office and Area Served
• 3.4 Key Players Metabolomics Biomarker Product Solution and Service
• 3.5 Date of Enter into Metabolomics Biomarker Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Metabolomics Biomarker Historic Market Size by Type (2015-2020)
• 4.2 Global Metabolomics Biomarker Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Metabolomics Biomarker Market Size by Application (2015-2020)
• 5.2 Global Metabolomics Biomarker Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Metabolomics Biomarker Market Size (2015-2020)
• 6.2 Metabolomics Biomarker Key Players in North America (2019-2020)
• 6.3 North America Metabolomics Biomarker Market Size by Type (2015-2020)
• 6.4 North America Metabolomics Biomarker Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Metabolomics Biomarker Market Size (2015-2020)
• 7.2 Metabolomics Biomarker Key Players in Europe (2019-2020)
• 7.3 Europe Metabolomics Biomarker Market Size by Type (2015-2020)
• 7.4 Europe Metabolomics Biomarker Market Size by Application (2015-2020)

8 China

• 8.1 China Metabolomics Biomarker Market Size (2015-2020)
• 8.2 Metabolomics Biomarker Key Players in China (2019-2020)
• 8.3 China Metabolomics Biomarker Market Size by Type (2015-2020)
• 8.4 China Metabolomics Biomarker Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Metabolomics Biomarker Market Size (2015-2020)
• 9.2 Metabolomics Biomarker Key Players in Japan (2019-2020)
• 9.3 Japan Metabolomics Biomarker Market Size by Type (2015-2020)
• 9.4 Japan Metabolomics Biomarker Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Metabolomics Biomarker Market Size (2015-2020)
• 10.2 Metabolomics Biomarker Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Metabolomics Biomarker Market Size by Type (2015-2020)
• 10.4 Southeast Asia Metabolomics Biomarker Market Size by Application (2015-2020)

11 India

• 11.1 India Metabolomics Biomarker Market Size (2015-2020)
• 11.2 Metabolomics Biomarker Key Players in India (2019-2020)
• 11.3 India Metabolomics Biomarker Market Size by Type (2015-2020)
• 11.4 India Metabolomics Biomarker Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Metabolomics Biomarker Market Size (2015-2020)
• 12.2 Metabolomics Biomarker Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Metabolomics Biomarker Market Size by Type (2015-2020)
• 12.4 Central & South America Metabolomics Biomarker Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Biocrates Life Sciences
  • 13.1.1 Biocrates Life Sciences Company Details
  • 13.1.2 Biocrates Life Sciences Business Overview
  • 13.1.3 Biocrates Life Sciences Metabolomics Biomarker Introduction
  • 13.1.4 Biocrates Life Sciences Revenue in Metabolomics Biomarker Business (2015-2020))
  • 13.1.5 Biocrates Life Sciences Recent Development
• 13.2 Biomark Diagnostics
  • 13.2.1 Biomark Diagnostics Company Details
  • 13.2.2 Biomark Diagnostics Business Overview
  • 13.2.3 Biomark Diagnostics Metabolomics Biomarker Introduction
  • 13.2.4 Biomark Diagnostics Revenue in Metabolomics Biomarker Business (2015-2020)
  • 13.2.5 Biomark Diagnostics Recent Development
• 13.3 Chenomx
  • 13.3.1 Chenomx Company Details
  • 13.3.2 Chenomx Business Overview
  • 13.3.3 Chenomx Metabolomics Biomarker Introduction
  • 13.3.4 Chenomx Revenue in Metabolomics Biomarker Business (2015-2020)
  • 13.3.5 Chenomx Recent Development
• 13.4 Creative Proteomics
  • 13.4.1 Creative Proteomics Company Details
  • 13.4.2 Creative Proteomics Business Overview
  • 13.4.3 Creative Proteomics Metabolomics Biomarker Introduction
  • 13.4.4 Creative Proteomics Revenue in Metabolomics Biomarker Business (2015-2020)
  • 13.4.5 Creative Proteomics Recent Development
• 13.5 Evotec
  • 13.5.1 Evotec Company Details
  • 13.5.2 Evotec Business Overview
  • 13.5.3 Evotec Metabolomics Biomarker Introduction
  • 13.5.4 Evotec Revenue in Metabolomics Biomarker Business (2015-2020)
  • 13.5.5 Evotec Recent Development
• 13.6 Human Metabolome Technologies
  • 13.6.1 Human Metabolome Technologies Company Details
  • 13.6.2 Human Metabolome Technologies Business Overview
  • 13.6.3 Human Metabolome Technologies Metabolomics Biomarker Introduction
  • 13.6.4 Human Metabolome Technologies Revenue in Metabolomics Biomarker Business (2015-2020)
  • 13.6.5 Human Metabolome Technologies Recent Development
• 13.7 Merck
  • 13.7.1 Merck Company Details
  • 13.7.2 Merck Business Overview
  • 13.7.3 Merck Metabolomics Biomarker Introduction
  • 13.7.4 Merck Revenue in Metabolomics Biomarker Business (2015-2020)
  • 13.7.5 Merck Recent Development
• 13.8 Metabolomic Diagnostics
  • 13.8.1 Metabolomic Diagnostics Company Details
  • 13.8.2 Metabolomic Diagnostics Business Overview
  • 13.8.3 Metabolomic Diagnostics Metabolomics Biomarker Introduction
  • 13.8.4 Metabolomic Diagnostics Revenue in Metabolomics Biomarker Business (2015-2020)
  • 13.8.5 Metabolomic Diagnostics Recent Development
• 13.9 Metabolon
  • 13.9.1 Metabolon Company Details
  • 13.9.2 Metabolon Business Overview
  • 13.9.3 Metabolon Metabolomics Biomarker Introduction
  • 13.9.4 Metabolon Revenue in Metabolomics Biomarker Business (2015-2020)
  • 13.9.5 Metabolon Recent Development
• 13.10 Ovid Therapeutics
  • 13.10.1 Ovid Therapeutics Company Details
  • 13.10.2 Ovid Therapeutics Business Overview
  • 13.10.3 Ovid Therapeutics Metabolomics Biomarker Introduction
  • 13.10.4 Ovid Therapeutics Revenue in Metabolomics Biomarker Business (2015-2020)
  • 13.10.5 Ovid Therapeutics Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer